Haemonetics Corp (HAE)
85.43
+0.51
(+0.60%)
USD |
NYSE |
Nov 21, 16:00
85.46
+0.04
(+0.04%)
Pre-Market: 20:00
Haemonetics Total Assets (Quarterly): 2.525B for Sept. 30, 2024
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
September 30, 2024 | 2.525B |
June 30, 2024 | 2.541B |
March 31, 2024 | 2.196B |
December 31, 2023 | 2.200B |
September 30, 2023 | 2.011B |
June 30, 2023 | 1.962B |
March 31, 2023 | 1.935B |
December 31, 2022 | 1.878B |
September 30, 2022 | 1.865B |
June 30, 2022 | 1.821B |
March 31, 2022 | 1.860B |
December 31, 2021 | 1.831B |
September 30, 2021 | 1.801B |
June 30, 2021 | 1.794B |
March 31, 2021 | 1.820B |
December 31, 2020 | 1.318B |
September 30, 2020 | 1.418B |
June 30, 2020 | 1.433B |
March 31, 2020 | 1.267B |
December 31, 2019 | 1.238B |
September 30, 2019 | 1.191B |
June 30, 2019 | 1.260B |
March 31, 2019 | 1.275B |
December 31, 2018 | 1.228B |
September 30, 2018 | 1.266B |
Date | Value |
---|---|
June 30, 2018 | 1.241B |
March 31, 2018 | 1.237B |
December 31, 2017 | 1.312B |
September 30, 2017 | 1.271B |
June 30, 2017 | 1.251B |
March 31, 2017 | 1.239B |
December 31, 2016 | 1.306B |
September 30, 2016 | 1.335B |
June 30, 2016 | 1.317B |
March 31, 2016 | 1.319B |
December 31, 2015 | 1.336B |
September 30, 2015 | 1.419B |
June 30, 2015 | 1.427B |
March 31, 2015 | 1.485B |
December 31, 2014 | 1.474B |
September 30, 2014 | 1.475B |
June 30, 2014 | 1.477B |
March 31, 2014 | 1.514B |
December 31, 2013 | 1.488B |
September 30, 2013 | 1.484B |
June 30, 2013 | 1.480B |
March 31, 2013 | 1.462B |
December 31, 2012 | 1.474B |
September 30, 2012 | 1.455B |
June 30, 2012 | 928.12M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
1.238B
Minimum
Dec 2019
2.541B
Maximum
Jun 2024
1.836B
Average
1.846B
Median
Total Assets (Quarterly) Benchmarks
Boston Scientific Corp | 38.08B |
Baxter International Inc | 26.68B |
Globus Medical Inc | 5.086B |
ResMed Inc | 7.222B |
Integra Lifesciences Holdings Corp | 4.066B |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 1.646B |
Shareholders Equity (Quarterly) | 878.85M |
Debt to Equity Ratio | 1.394 |
Current Ratio | 3.489 |
Net Debt Paydown Yield | -2.27% |